DMD and Duchenne muscular dystrophy: Due to the robust phenotype of dystrophin-deficient skeletal muscle to ECCs, research laboratories have established and even developed their own preparations and protocols to understand the mechanisms of strength loss or to test preclinical therapies for DMD.